Pure Global

QUIMICOS Y REACTIVOS S.A.S- SIGLA QUIMIREL S.A.S - Authorized Company ProfileQUIMICOS Y REACTIVOS S.A.S- ACRONYM QUIMIREL S.A.S

Explore comprehensive authorized company profile for QUIMICOS Y REACTIVOS S.A.S- SIGLA QUIMIREL S.A.S through Pure Global AI's free Colombia medical device database. This company manufactures 160 medical devices registered with INVIMA across 3 risk classes. Their registration history spans from Feb 28, 2023 to Oct 27, 2033.

This page provides detailed insights including recent registrations, risk class distribution (I: 85, Unspecified: 1, II: 74), and complete regulatory information from the official Colombia INVIMA medical device database with bilingual Spanish/English support. Pure Global AI offers free access to Colombia's complete medical device registry.

Free Authorized Company Profile
Powered by Pure Global AI
160 Devices
3 Risk Classes
QUIMICOS Y REACTIVOS S.A.S- SIGLA QUIMIREL S.A.S
QUIMICOS Y REACTIVOS S.A.S- ACRONYM QUIMIREL S.A.S
Authorized Company
160
Total Devices
3
Risk Classes
2023
Earliest
2033
Latest
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Recent Registrations
Latest 20 INVIMA device registrations

SULFAMETOXASOL TRIMETROPIN X 25 ยตG

SULFAMETOXASOL TRIMETROPIN X 25 ยตG

16e0423e49082f363f1fa26491e08ba5

II
Oct 27, 2033

XPECT ROTAVIRUS TEST R24655

XPECT ROTAVIRUS TEST R24655

640512ee0403a451a17aff8470ed6467

II
Aug 01, 2033

G C AGAR BASE

G C AGAR BASE

cba806d3b983b120d49efe27be6f2aac

II
Jul 21, 2033

2.SULFONAMIDAS

2.SULFONAMIDAS

3c44b426f64496a3e982be5e0dd6e47d

II
Dec 15, 2031

3.TETRACICLINA

3.TETRACICLINA

050a073b0b72d938501a8b03f6849420

II
Dec 15, 2031

5 NITROIMIDAZOL

5 NITROIMIDAZOL

e13fb9276410d05f714eba96bce808eb

II
Dec 15, 2031

4.NITROFURANOS

4.NITROFURANOS

12b8ba0956b6a51d67deb989e36c7840

II
Dec 15, 2031

1.POLIXIMINA

1.POLIXIMINA

d350948de89b930b57a0fbe6ba6c888c

II
Dec 15, 2031

5. ESTREPTOGRAMINAS

5. ESTREPTOGRAMINAS

5a590b0c74ce7dcff0857f24b7967acf

I
Jun 01, 2031

12. MISCELANEOS

12. MISCELLANEOUS

af30005c19b54a63a1a7607ab8cc56c8

I
Jun 01, 2031

3.CARBAPENEMAS

3.CARBAPENEMAS

85cc56cc1c140f835968d9450ccbd7eb

I
Jun 01, 2031

13. PENICILINA

13. PENICILLIN

f285993ada9e49d2454dd18e813b14c4

I
Jun 01, 2031

11. MACROLIDO

11. MACROLIDO

74c42eca6449d5bafc1a505f18167454

I
Jun 01, 2031

9. GLUCOPEPTIDOS

9. GLUCOPEPTIDOS

c4b61d5946df14821442e7e129565b26

I
Jun 01, 2031

2. ANTIFUNGICO

2. ANTIFUNGICO

77eda4c7909d8eee9f6672a86800df80

I
Jun 01, 2031

10. LINCOSAMINAS

10. LINCOSAMINAS

e62f7894c7ec1dc86b3a198f18cb9d82

I
Jun 01, 2031

15. OXAZOLIDINONAS

15. OXAZOLIDINONAS

478f55d080257d1500b0d4b59d814b8a

I
Jun 01, 2031

1.AMINOGLUCOSIDOS

1.AMINOGLUCOSIDOS

6028eb0fe8f9dc8a88acdc4fd1fd15e5

I
Jun 01, 2031

4. CEFALOSPORINA

4. CEPHALOSPORIN

71dbe78ee5fc671a1f3c847cc33f670f

I
Jun 01, 2031

14. QUINOLONA

14. QUINOLONA

ae8219bdeba17863d119015c61afb473

I
Jun 01, 2031
Risk Class Distribution
Devices by risk class
I
85
53.1% of total
II
74
46.3% of total
Unspecified
1
0.6% of total